Skip to main content
Published locations for Advanced refractory ROS1+ NSCLC: Lorlatinib is safe and effective in real-world setting
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Advanced refractory ROS1+ NSCLC: Lorlatinib is safe and effective in real-world setting
User login
Username
Password
Reset your password
/content/advanced-refractory-ros1-nsclc-lorlatinib-safe-and-effective-real-world-setting
/hematology-oncology/article/254062/lung-cancer/advanced-refractory-ros1-nsclc-lorlatinib-safe-and